Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Palliative Care × Head & Neck × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Thoracic 3 Breast 3 Gynecologic 2 Gastrointestinal 2 Sarcoma 1 Plasma cell 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Genitourinary 1 Dermatologic 1

Conditions

Oropharyngeal Neoplasms 1

Interventions

Cisplatin 102 Cetuximab 83 pembrolizumab 66 Radiotherapy 54 Carboplatin 46 Radiotherapy, Intensity-Modulated 42 Docetaxel 38 Nivolumab 36 Fluorouracil 35 Paclitaxel 34 Radiation 15 durvalumab 14 Erlotinib Hydrochloride 13 lenvatinib 12 Ipilimumab 12 Gemcitabine 12 Bevacizumab 12 Albumin-Bound Paclitaxel 11 vandetanib 10 Platinum 10 Everolimus 10 Drug Therapy 10 epacadostat 9 Pemetrexed 9 Radiosurgery 8 Panitumumab 8 Cyclophosphamide 8 130-nm albumin-bound paclitaxel 8 tremelimumab 7 Surgical Procedures, Operative 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04952922 2025-08-08

FUNQOLR

Royal Marsden NHS Foundation Trust

25 enrolled 8 charts

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡